Home / XTNT : AMEX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does XTNT make money? Does XTNT have pricing power? What's the Earnings Whisper? Will XTNT profit more as the business scales? What is XTNT's management track record? Is XTNT's current price justified?

Xtant Medical Holdings, Inc.

$0.35 -$0.40 (-53.71%)

AMEX · 11 Sep 2026 20:00 UTC

Previous Close

$0.34

Day Range

$0.32$0.35

Year Range

$0.27$0.95

Market Cap

48.5M

AVG Volume

1.2M

Trailing/Forward PE

-4.2/-

PEG ratio

0.07

Dividend Yield

Next Earnings Date

2026-11-10

Primary Exchange

New York Stock Exchange Arca

Revenue (USD)

XTNT Revenue (USD) by year
Period	Revenue (USD)
2025	133.93M
2024	117.27M
2023	91.3M
2022	57.97M
2021	55.26M
2020	53.34M
2019	64.68M
2018	72.2M
2017	82.61M
2016	90M

Net Income (USD)

XTNT Net Income (USD) by year
Period	Net Income (USD)
2025	4.97M
2024	-16.45M
2023	660K
2022	-8.48M
2021	-4.85M
2020	-7.02M
2019	-8.22M
2018	-70.1M
2017	-51.79M
2016	-19.49M

Operating Income (USD)

XTNT Operating Income (USD) by year
Period	Operating Income (USD)
2025	7.28M
2024	-12.07M
2023	-10.16M
2022	-6.75M
2021	-3.85M
2020	-751K
2019	-2.25M
2018	-60.08M
2017	-37.22M
2016	-7.48M

EBITDA (USD)

XTNT EBITDA (USD) by year
Period	EBITDA (USD)
2025	15.89M
2024	-7.88M
2023	5.08M
2022	-5.43M
2021	-2.52M
2020	1.33M
2019	791K
2018	-53.9M
2017	-36.32M
2016	-783.47K

Cash Flows (USD)

XTNT Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	10.16M
2024	-16.01M
2023	-10.97M
2022	-7.11M
2021	-1.68M
2020	-2.28M
2019	-1.29M
2018	588K
2017	-2.18M
2016	-19.05M

EPS (USD)

XTNT EPS (USD) by year
Period	EPS (USD)
2025	0.03
2024	-0.12
2023	-0
2022	-0.09
2021	-0.06
2020	-0.5
2019	-0.62
2018	-5.6
2017	-34.06
2016	-17.73

Expenses (USD)

XTNT Expenses (USD) by year
Period	Expenses (USD)
2025	79.37M
2024	84.4M
2023	67.08M
2022	40.66M
2021	38.46M
2020	36.69M
2019	45.59M
2018	47.34M
2017	59.69M
2016	68.3M

Cash & Debt (USD)

XTNT Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	17.05M
2024	6.2M
2023	5.71M
2022	20.3M
2021	18.24M
2020	2.34M
2019	5.24M
2018	6.8M
2017	2.86M
2016	2.58M

Debt ratios

XTNT Debt ratios by year
Period	Debt ratios
2025	1.52
2024	-2.69
2023	-11.6
2022	0.55
2021	0.03
2020	-0.18
2019	-0.81
2018	-0.74

Margins

XTNT Margins by year
Period	Margins
2025	62.92%
2024	58.17%
2023	60.75%
2022	55.44%
2021	58.79%
2020	64.48%
2019	65.73%
2018	60.23%
2017	61.39%
2016	69.21%

Return on Capital

XTNT Return on Capital by year
Period	Return on Capital
2025	9.76%
2024	-38.29%
2023	1.29%
2022	-24.83%
2021	-15.7%
2020	-48.39%
2019	18.6%
2018	160.15%
2017	88.24%
2016	275.59%

Shares Outstanding

XTNT Shares Outstanding by year
Period	Shares Outstanding
2025	139.83M
2024	138.98M
2023	130.02M
2022	108.34M
2021	87.03M
2020	20.87M
2019	13.26M
2018	13.16M
2017	1.51M
2016	1.21M

Book Value Per Share (USD)

XTNT Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	0.36
2024	0.31
2023	0.39
2022	0.32
2021	0.35
2020	0.7
2019	-3.33
2018	-3.33
2017	-38.85
2016	-5.86

Total Assets (USD)

XTNT Total Assets (USD) by year
Period	Total Assets (USD)
2025	94.14M
2024	93.84M
2023	92.61M
2022	60.23M
2021	54.69M
2020	41.47M
2019	43.16M
2018	46.42M
2017	105.7M
2016	144.1M

Employee Count

XTNT Employee Count by year
Period	Employee Count
2025	151
2024	217
2023	207
2022	134
2021	116
2020	110
2019	141
2018	166
2017	174
2016	253

PE Ratio

XTNT PE Ratio by year
Period	PE Ratio
Aug 26	34.01
Jul 26	32.91
Jul 26	32.83
Jul 26	34.46
Jul 26	32.15
Jul 26	31.62
Jun 26	32.17
Jun 26	33.74
Jun 26	33.69
Jun 26	34.91
May 26	35.38
May 26	36.76
May 26	34.91
May 26	14.62
May 26	15.45
Apr 26	14.74
Apr 26	13.54
Apr 26	13.5
Apr 26	13.84
Mar 26	44
Mar 26	48.91
Mar 26	49.41
Mar 26	49.33
Feb 26	45.37
Feb 26	46.15
Feb 26	46.5
Feb 26	47.04
Jan 26	47.1
Jan 26	51.94
Jan 26	52.91
Jan 26	54.26
Jan 26	59.43
Dec 25	61.74
Dec 25	61.26
Dec 25	57.68
Dec 25	49.01
Nov 25	46.96
Nov 25	49.41
Nov 25	51.88
May 24	159.63
May 24	167.45
Apr 24	187.15
Apr 24	163.51
Apr 24	164.93
Apr 24	186.43
Mar 24	54.44
Mar 24	47.92
Mar 24	53.97
Mar 24	54.9
Mar 24	54.44
Feb 24	48.39
Feb 24	49.32
Feb 24	49.79
Feb 24	49.79
Jan 24	48.39
Jan 24	50.72
Jan 24	52.11
Jan 24	55.37
Dec 23	52.58
Dec 23	56.77
Dec 23	51.18
Dec 23	59.09
Dec 23	60.49
Nov 23	59.56
Nov 23	53.51

Free Cash Flow Yield

XTNT Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-1.44%
Sep 26	-1.32%
Aug 26	-1.29%
Aug 26	-1.53%
Aug 26	-1.63%
Aug 26	12.51%
Jul 26	12.93%
Jul 26	12.96%
Jul 26	12.35%
Jul 26	13.23%
Jul 26	13.46%
Jun 26	13.23%
Jun 26	12.61%
Jun 26	12.63%
Jun 26	12.19%
May 26	12.03%
May 26	11.58%
May 26	12.19%
May 26	13.98%
May 26	13.23%
Apr 26	13.87%
Apr 26	15.09%
Apr 26	15.14%
Apr 26	14.77%
Mar 26	6.71%
Mar 26	6.04%
Mar 26	5.98%
Mar 26	5.99%
Feb 26	6.51%
Feb 26	6.4%
Feb 26	6.35%
Feb 26	6.28%
Jan 26	6.27%
Jan 26	5.69%
Jan 26	5.58%
Jan 26	5.44%
Jan 26	4.97%
Dec 25	4.78%
Dec 25	4.82%
Dec 25	5.12%
Dec 25	6.03%
Nov 25	6.29%
Nov 25	5.98%
Nov 25	5.69%
Nov 25	-2.7%
Oct 25	-2.31%
Oct 25	-2.54%
Oct 25	-2.86%
Oct 25	-2.84%
Oct 25	-3.13%
Sep 25	-3.17%
Sep 25	-3.13%
Sep 25	-3.22%
Sep 25	-3.23%
Aug 25	-3.18%
Aug 25	-3.2%
Aug 25	-3.22%
Aug 25	-10.57%
Aug 25	-11.7%
Jul 25	-10.57%
Jul 25	-10.42%
Jul 25	-10.01%
Jul 25	-9.47%
Jun 25	-10.42%
Jun 25	-10.94%
Jun 25	-10.53%
Jun 25	-9.43%
May 25	-9.93%
May 25	-8.9%
May 25	-9.89%
May 25	-22.83%
May 25	-24.4%
Apr 25	-22.59%
Apr 25	-25.66%
Apr 25	-28.3%
Apr 25	-24.51%
Mar 25	-23.54%
Mar 25	-21.33%
Mar 25	-24%
Mar 25	-24.98%
Feb 25	-25.08%
Feb 25	-22.84%
Feb 25	-21.37%
Feb 25	-22.05%
Jan 25	-20.8%
Jan 25	-22.02%
Jan 25	-24.6%
Jan 25	-25.64%
Jan 25	-24.27%
Dec 24	-27.56%
Dec 24	-35.53%
Dec 24	-35.03%
Dec 24	-31.64%
Nov 24	-31.98%
Nov 24	-32.37%
Nov 24	-29.79%
Nov 24	-25.59%
Nov 24	-25.17%
Oct 24	-25.04%
Oct 24	-24.4%

Price to Sales

XTNT Price to Sales by year
Period	Price to Sales
Sep 26	0.44
Sep 26	0.48
Aug 26	0.49
Aug 26	0.42
Aug 26	0.39
Aug 26	0.51
Jul 26	0.49
Jul 26	0.49
Jul 26	0.52
Jul 26	0.48
Jul 26	0.47
Jun 26	0.48
Jun 26	0.51
Jun 26	0.5
Jun 26	0.52
May 26	0.53
May 26	0.55
May 26	0.52
May 26	0.54
May 26	0.57
Apr 26	0.55
Apr 26	0.5
Apr 26	0.5
Apr 26	0.51
Mar 26	0.58
Mar 26	0.64
Mar 26	0.65
Mar 26	0.65
Feb 26	0.6
Feb 26	0.61
Feb 26	0.61
Feb 26	0.62
Jan 26	0.62
Jan 26	0.68
Jan 26	0.7
Jan 26	0.71
Jan 26	0.78
Dec 25	0.81
Dec 25	0.81
Dec 25	0.76
Dec 25	0.64
Nov 25	0.62
Nov 25	0.65
Nov 25	0.68
Nov 25	0.82
Oct 25	0.96
Oct 25	0.87
Oct 25	0.77
Oct 25	0.78
Oct 25	0.71
Sep 25	0.7
Sep 25	0.71
Sep 25	0.69
Sep 25	0.69
Aug 25	0.7
Aug 25	0.69
Aug 25	0.69
Aug 25	0.73
Aug 25	0.66
Jul 25	0.73
Jul 25	0.74
Jul 25	0.77
Jul 25	0.81
Jun 25	0.74
Jun 25	0.7
Jun 25	0.73
Jun 25	0.81
May 25	0.77
May 25	0.86
May 25	0.78
May 25	0.6
May 25	0.56
Apr 25	0.6
Apr 25	0.53
Apr 25	0.48
Apr 25	0.56
Mar 25	0.58
Mar 25	0.64
Mar 25	0.57
Mar 25	0.55
Feb 25	0.61
Feb 25	0.66
Feb 25	0.71
Feb 25	0.69
Jan 25	0.73
Jan 25	0.69
Jan 25	0.62
Jan 25	0.59
Jan 25	0.63
Dec 24	0.55
Dec 24	0.43
Dec 24	0.43
Dec 24	0.48
Nov 24	0.47
Nov 24	0.47
Nov 24	0.51
Nov 24	0.62
Nov 24	0.63
Oct 24	0.63
Oct 24	0.65

EV/EBITDA

XTNT EV/EBITDA by year
Period	EV/EBITDA
Aug 26	5.53
Jul 26	5.36
Jul 26	5.35
Jul 26	5.6
Jul 26	5.25
Jul 26	5.16
Jun 26	5.25
Jun 26	5.49
Jun 26	5.49
Jun 26	5.67
May 26	5.75
May 26	5.96
May 26	5.67
May 26	5.31
May 26	5.57
Apr 26	5.34
Apr 26	4.97
Apr 26	4.96
Apr 26	5.06
Mar 26	9.1
Mar 26	9.89
Mar 26	9.97
Mar 26	9.95
Feb 26	9.32
Feb 26	9.44
Feb 26	9.5
Feb 26	9.59
Jan 26	9.59
Jan 26	10.37
Jan 26	10.53
Jan 26	10.74
Jan 26	11.58
Dec 25	11.95
Dec 25	11.87
Dec 25	11.29
Dec 25	9.9
Nov 25	9.57
Nov 25	9.97
Nov 25	10.36
Nov 25	29.49
Oct 25	33.35
Oct 25	30.96
Oct 25	28.19
Oct 25	28.36
Oct 25	26.37
Sep 25	26.1
Sep 25	26.36
Sep 25	25.79
Sep 25	25.76
Aug 25	26.03
Aug 25	25.91
Aug 25	25.81
Nov 24	41.62
Nov 24	42.1
Oct 24	42.26
Oct 24	43.04
Oct 24	45.85
Oct 24	47.4
Sep 24	49.61
Sep 24	51.41
Sep 24	44.44
Sep 24	43.81
Aug 24	53.48
Aug 24	49.29
Aug 24	47.07
Aug 24	46.9
Aug 24	30.93
Jul 24	33.42
Jul 24	33.5
Jul 24	32.38
Jul 24	30.5
Jun 24	29.49
Jun 24	31.3
Jun 24	33.86
Jun 24	32.66
May 24	32.74
May 24	33.86
May 24	32.74
May 24	24.26
May 24	25.28
Apr 24	27.84
Apr 24	24.77
Apr 24	24.95
Apr 24	27.74
Mar 24	29.34
Mar 24	26.14
Mar 24	29.11
Mar 24	29.57
Mar 24	29.34
Feb 24	26.37
Feb 24	26.83
Feb 24	27.05
Feb 24	27.05
Jan 24	26.37
Jan 24	27.51
Jan 24	28.2
Jan 24	29.8
Dec 23	28.43
Dec 23	30.49
Dec 23	27.74

Price/Operating Cashflow

XTNT Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	85.09
Sep 26	92.28
Aug 26	94.49
Aug 26	79.95
Aug 26	75.05
Aug 26	6.79
Jul 26	6.57
Jul 26	6.55
Jul 26	6.87
Jul 26	6.41
Jul 26	6.31
Jun 26	6.42
Jun 26	6.73
Jun 26	6.72
Jun 26	6.96
May 26	7.06
May 26	7.33
May 26	6.96
May 26	5.8
May 26	6.12
Apr 26	5.84
Apr 26	5.37
Apr 26	5.35
Apr 26	5.48
Mar 26	9.84
Mar 26	10.94
Mar 26	11.05
Mar 26	11.03
Feb 26	10.15
Feb 26	10.32
Feb 26	10.4
Feb 26	10.52
Jan 26	10.53
Jan 26	11.61
Jan 26	11.83
Jan 26	12.13
Jan 26	13.29
Dec 25	13.8
Dec 25	13.7
Dec 25	12.9
Dec 25	10.96
Nov 25	10.5
Nov 25	11.05
Nov 25	11.6
Nov 25	69.85
Oct 25	81.63
Oct 25	74.34
Oct 25	65.91
Oct 25	66.42
Oct 25	60.33
Sep 25	59.53
Sep 25	60.32
Sep 25	58.56
Sep 25	58.47
Aug 25	59.31
Aug 25	58.94
Aug 25	58.63
Jul 22	59.92
Jul 22	59.47
Jul 22	59.93
Jul 22	57.83
Jul 22	56.4
Jun 22	54.7
Jun 22	57.58
Jun 22	66.69
Jun 22	76.36
May 22	61.69
May 22	63.45
May 22	60.06
May 22	70.51
Apr 22	128.64
Apr 22	128.86
Apr 22	136.79
Apr 22	134.8
Apr 22	138.77
Mar 22	133.53
Mar 22	126.87
Mar 22	130.84
Mar 22	78.2
Feb 22	66.24
Feb 22	61.44
Feb 22	59.78
Feb 22	58.65
Jan 22	53.08
Jan 22	59.11
Jan 22	60.32
Jan 22	53.87
Dec 21	52.13
Dec 21	61.44
Dec 21	67.97
Dec 21	68.28
Dec 21	65.51
Nov 21	72.84
Nov 21	82.85
Nov 21	102.4
Nov 21	55.31
Oct 21	55.8
Oct 21	57.25
Oct 21	53.86
Oct 21	55.31

Price to Book

XTNT Price to Book by year
Period	Price to Book
Sep 26	1.21
Sep 26	1.31
Aug 26	1.35
Aug 26	1.14
Aug 26	1.07
Aug 26	1.28
Jul 26	1.24
Jul 26	1.23
Jul 26	1.29
Jul 26	1.21
Jul 26	1.19
Jun 26	1.21
Jun 26	1.27
Jun 26	1.27
Jun 26	1.31
May 26	1.33
May 26	1.38
May 26	1.31
May 26	1.43
May 26	1.51
Apr 26	1.44
Apr 26	1.32
Apr 26	1.32
Apr 26	1.35
Mar 26	1.53
Mar 26	1.7
Mar 26	1.72
Mar 26	1.71
Feb 26	1.58
Feb 26	1.6
Feb 26	1.62
Feb 26	1.63
Jan 26	1.64
Jan 26	1.81
Jan 26	1.84
Jan 26	1.89
Jan 26	2.07
Dec 25	2.15
Dec 25	2.13
Dec 25	2
Dec 25	1.7
Nov 25	1.63
Nov 25	1.72
Nov 25	1.8
Nov 25	2.16
Oct 25	2.53
Oct 25	2.3
Oct 25	2.04
Oct 25	2.06
Oct 25	1.87
Sep 25	1.84
Sep 25	1.87
Sep 25	1.81
Sep 25	1.81
Aug 25	1.84
Aug 25	1.82
Aug 25	1.81
Aug 25	2.03
Aug 25	1.83
Jul 25	2.03
Jul 25	2.05
Jul 25	2.14
Jul 25	2.26
Jun 25	2.05
Jun 25	1.96
Jun 25	2.03
Jun 25	2.27
May 25	2.16
May 25	2.41
May 25	2.16
May 25	1.63
May 25	1.53
Apr 25	1.65
Apr 25	1.45
Apr 25	1.32
Apr 25	1.52
Mar 25	1.58
Mar 25	1.75
Mar 25	1.55
Mar 25	1.49
Feb 25	1.51
Feb 25	1.65
Feb 25	1.77
Feb 25	1.71
Jan 25	1.82
Jan 25	1.72
Jan 25	1.54
Jan 25	1.47
Jan 25	1.56
Dec 24	1.37
Dec 24	1.06
Dec 24	1.08
Dec 24	1.19
Nov 24	1.18
Nov 24	1.17
Nov 24	1.27
Nov 24	1.52
Nov 24	1.55
Oct 24	1.55
Oct 24	1.6

No video analysis for this stock yet. Request one from our team.

News: XTNT

prnewswire.com · 27 Aug 2026

Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market

Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™ BELGRADE, Mont., Aug. 27, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a Henry Schein, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand Prolifica™ through its commercial network.

seekingalpha.com · 11 Aug 2026

Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript

prnewswire.com · 11 Aug 2026

Xtant Medical Reports Second Quarter 2026 Financial Results

Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and webcast today, August 11 th, at 8:30am ET BELGRADE, Mont., Aug. 11, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the second quarter ended June 30, 2026.

prnewswire.com · 6 Aug 2026

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

BELGRADE, Mont., Aug. 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the second quarter ended June 30, 2026, before the start of trading on Tuesday, August 11, 2026.

prnewswire.com · 4 Aug 2026

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

BELGRADE, Mont., Aug. 4, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 46th Annual Growth Conference, which is being held August 11-13, 2026, in Boston.